Three new indole alkaloids from Rauvolfia yunnanensis
Abstract
One rare tetracyclic macroline-type indole alkaloid, named rauvoyunine A(1), and two new picraline-type alkaloids rauvoyunines B and C(2 and 3) were isolated from the aerial parts of Rauvolfia yunnanensis. Their structures were elucidated on the basis of extensive spectroscopic analysis. Compounds 2 and 3 were evaluated for their in vitro cytotoxicity against five human tumor cell lines.Keywords
Rauvolfia yunnanensis indole alkaloid rauvoyunineIntroduction
The plants of genus Rauvolfia, widely distributed in America, Africa, Asia, and Oceania, 1 are well-known rich sources of unique heterocyclic alkaloids with monoterpene indole skeletons. These alkaloids have attracted great interests from biological and therapeutic aspects, due to their anticancer, 2 antimalarial, 3 antihypertensive, 4 and sedative5 properties.
Rauvolfia yunnanensis Tsiang, belonging to the Apocynaceae, is indigenous to southwestern China, and its roots are utilized locally for the remedy of scab1. Recently, several structurally interesting indole alkaloids were isolated from this plant.6-8 As one part of our research program exploring bioactive monoterpene indole alkaloids from Chinese species of Rauvolfia, phytochemical analysis from the methanol extract of aerial parts of R. yunnanensis led to the isolation of three new alkaloids, rauvoyunines A–C (1–3). This paper reports the isolation and structure elucidation of new compounds and cytotoxic evaluation of selected compounds.
Results and Discussion
Compound 1, obtained as amorphous powder, has a molecular formula of C21H28N2O3 based on HRESIMS (pos.), showing a quasi-molecular ion peak at m/z 357.2185 (calc. for C21H29N2O3, 357.2178). The UV spectrum showed absorptions at λmax 228, 282, and 303 nm typical of a substituted indole chromophore.9 The IR spectrum showed absorptions at 3432 and 1628 cm–1, attributed to hydroxy and olefin groups, respectively. The 1H NMR spectrum (Table 1) showed signals for an aromatic AMX spin system at δH 6.73 (dd, J = 8.7 and 2.3 Hz), 6.85 (d, J = 2.3 Hz), and 7.17 (d, J = 8.7 Hz), typical of an indole moiety substituted by a hydroxy group at 10 or 11 position, signals characteristic of an ethylidene group at δH 1.44 (d, J = 6.8 Hz) and 5.58 (q, J = 6.8 Hz), singlets for Nmethyl groups at δH 2.55 and 3.59, and resonances of two hydroxymethyl groups, one at δH 3.75 (dd, J = 10.5 and 3.7 Hz) and 3.91 (dd, J = 10.5 and 5.5 Hz), and another at δH 4.02 (2H, s). The 13C NMR (DEPT) spectrum (Table 1) exhibited six sp2 quaternary carbons (δC 151.8, 140.3, 134.0, 132.3, 127.8, and 106.2), four sp2 methines (δC 124.8, 112.2, 110.6, and 103.4), four sp3 methines (δC 58.7, 55.5, 47.7, and 30.2), four sp3 methylenes (δC 66.0, 64.1, 30.5, and 23.7), and three methyl groups (δC 41.5, 29.3, and 13.1). The above-mentioned data, together with the presence of nine degrees of unsaturation suggested that 1 was an indole alkaloid with tetracyclic macroline skeleton.10, 11 This conclusion is supported by the HMBC (Figure 1) three-bond correlations of H-5 to C-3, C-15, and C-17, H-16 to C-6 and C-14, and H-15 to C-3, C-17, and C-19. In addition, the m-coupling doublet at δH 6.85 (J = 2.3 Hz) showed an HMBC correlation with C-7 and a ROESY correlation with H-6β, indicating the hydroxyl at C-10. HMBC cross-peaks of H-18 to C-19 and C-20, and H-19 to C-15 and C-20 located the ethylidene side chain at C-20, and cross-peaks of H-17 to C-5, C-15, and C-16, and H-21 to C-15, C-19, and C-20 revealed that the two hydroxymethyl group was adjacent to C-16 and C-20, respectively. The position of each methyl group was confirmed by HMBC correlations from N(1)-Me to C-2 and C-13, and N(4)-Me to C-3 and C-5.
Key HMBC and ROESY correlations of 1.
1H NMR and 13C NMR spectroscopic data for rauvoyunines A−C (1−3) (δ in ppm, J in Hz).
The relative stereochemistry of 1 was elucidated by ROESY experiments (Figure 1). The ROESY spectrum exhibited correlations of H-16↔H-6β and H-3↔N(4)-Me↔H-5, fixing the two bridgehead hydrogen atoms as α orientation, revealing the stereochemistry of H-16 as β-oriented. The ROESY correlation between H-14α and the hydroxymethyl proton at C-20 indicated that C-20 was α-oriented and H-15 was β-oriented. The ROESY correlations of Me-18↔H-15 and H-19↔H-21 confirmed that the ethylidene side chain had an Econfiguration. Consequently, the structure of compound 1 was determined as shown, named rauvoyunine A.
|
Compound 2 was obtained as amorphous powder. Its molecular formula was determined to be C23H26N2O6 on the basis of HRESIMS (pos.), showing a quasi-molecular ion peak at m/z 427.1868 (calc. for C23H27N2O6, 427.1869). The UV spectrum showed maximum absorption at 292 nm, and the IR spectrum implied the presence of carbonyl (1738 cm–1) functionality. The 1H NMR spectra (Table 1) showed the presence of three aromatic protons, an ethylidene side chain, a methyl ether, and an acetyl. The 13C NMR spectra (Table 1) revealed 23 carbon signals due to six sp2 quaternary carbons, four sp2 methines, three sp3 quaternary carbons, three sp3 methines, four sp3 methylenes, and three methyl groups. These spectroscopic features suggested that 2 had a picraline-type skeleton.13, 14 The three observed aromatic resonances at δH 7.11 (d, J = 8.8 Hz), 6.20 (dd, J = 8.8, 2.2 Hz), and 6.19 (d, J = 2.2 Hz) combined with the fact that a hydroxylated carbon signal was detected at δC 158.6 (s) suggested that an OH group located at C-10 or C-11. Finding HMBC correlation from the o-coupling doublet at δH 7.11 (J = 8.8 Hz) to C-7 at δC 53.2 (s) and ROESY correlation between the doublet and H-6α further confirmed placement of hydroxyl at C-11. Two geminally coupled proton signals at δH 3.85 and 4.52 (each d, J = 11.1 Hz) showed correlations with an O-acetyl carbonyl carbon at δC 171.9, indicating that an acetoxy group was located at C-17. An methoxy singlet at δH 3.66 showed correlation to C-22 at δC 173.7, allowing assignment of methyl ether at C-22 position. The ROESY cross-peak between H-17a and H-14β indicated that C-17 was β-oriented, which was further supported by the presence of an NMR signal of the acetyl methyl group at δH 1.62 (the noticeable upfield shift being due to the shielding by the aromatic ring current).15 ROESY cross-peaks of H-14α↔H-21α↔H-3 and H-21β↔H-5 revealed that the configuration of H-3 and H-5 were α and β, respectively. The ethylidene moity was assigned to be E-type since the correlations of H-18↔H-15 and H-19↔H-21 were observed. Therefore, the structure of 2 was unambiguously elucidated as 11-hydroxypicraline, named rauvoyunine B.
Compound 3, obtained as amorphous powder, possessed a molecular formula of C32H36N2O9, as evidenced by HRESIMS (pos.) at m/z 593.2496 (calc. for C32H37N2O9, 593.2499), in combination with 1H and 13C NMR (DEPT) spectra (Table 1), and appropriate for 16 degrees of unsaturation. The UV spectrum showed maximum absorption at 269 nm. Its IR spectrum revealed absorption bands of carbonyl (1722 cm–1). The 1H NMR data showed signals of three aromatic protons at δH 6.04 (br. d, J = 8.3 Hz), 6.26 (br. s), and 7.29 (d, J = 8.3 Hz), an ethylidene group at δH 1.62 (d, J = 6.7 Hz) and 5.48 (q, J = 6.7 Hz), two methoxy groups at δH 3.45 (s) and 3.64 (s), and a 3′, 4′, 5′-trimethoxybenzoyloxy unit, based on the presence of two aromatic protons at δH 6.94 (2H, s) and three overlapped methoxy groups at δH 3.87 (9H, s). The 13C NMR (DEPT) data exhibited ten sp2 quaternary carbons, six sp2 methines, three sp3 quaternary carbons, three sp3 methines, four sp3 methylenes, and six methyl groups. These spectroscopic features were closely related to those of 2, but it was evident that 3 had a trimethoxybenzoyloxy unit instead of the acetoxy moity at C-17 and a methoxyl group instead of the hydroxy group at C-11. This was also supported by HMBC correlations from H-17 to C-7′ and correlation from methoxy protons at δH 3.45 (s) to C-11 at δC 160.1. The ROESY cross-peaks of Me-18↔H-15 and H-19↔H-21 confirmed that the ethylidene possessed an E-configuration. The cross-peak of 17a↔H-14β indicated that the stereochemistry of C-16 was identical to that of 2. Since the J3 14, J14 15, and J5 6 values were essentially unchanged compared to 2, it is safe to deduce that the ring junction stereochemistry remain intact. Thus, the structure of 3 was established to be 11-methoxyburnamine-17-O-3′, 4′, 5′-trimethoxybenzoate and named as rauvoyunine C.
Compounds 2 and 3 were evaluated for their cytotoxicities against five human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7, and SW-480) using the MTT method as reported previously, 15 however, all tested compounds were inactive, and they showed IC50 values > 40 μM.
Experimental Section
General Experimental Procedures. Optical rotations were measured on a Jasco P-1020 automatic digital polarimeter. IR spectra were obtained using a Bruker Tensor 27 FT-IR spectrometer with KBr pellets. NMR spectra were acquired with a Bruker DRX-500 instrument at room temperature. ESIMS (including HRESIMS) were measured on API QSTAR Pulsar i mass spectrometers. Silica gel (200−300 mesh, Qingdao Marine Chemical Inc., China) and Sephadex LH-20 (Amersham Biosciences, Sweden) were used for column chromatography. Fractions were monitored by TLC (Qingdao Marine Chemical Inc., China) in combination with reversedphase HPLC (Agilent 1200, Extend-C18 column, 5 μm, 4.6 × 150 mm).
Plant Material. The aerial parts of R. yunnanensis were collected in Xishuangbanna of Yunnan Province, China, in May 2008 and were identified by Prof. Yu Chen of Kunming Institute of Botany, Chinese Academy of Sciences. The voucher specimen was deposited at BioBioPha Co., Ltd.
Extraction and Isolation. The air-dried and powdered aerial parts of R. yunnanensis (6.5 kg) were extracted three times with methanol (3 × 50 L, each 3 days) at room temperature and filtered. The filtrate was evaporated under reduced pressure to get a residue (~480 g), which was fractionized by silica gel (200–300 mesh) CC, eluted with a gradient solvent system of petroleum ether-acetone and then MeOH to yield five fractions A–E. Fraction D, eluted by 100% acetone, was separated on silica gel (CHCl3-MeOH, 100:1→30:1) to give two subfractions D1 and D2, Fr. D2 was further isolated and purified by Sephadex LH-20, silica gel (CHCl3-MeOHammonia, 100:1:0.1) to afford 3 (28 mg). Fraction E, eluted by 100% methanol, was separated on silica gel (CHCl3-MeOH, 30:1→10:1) to give four subfractions E1–E4, Fr. E4 was further isolated and purified by Sephadex LH-20, and then silica gel (CHCl3-MeOH-ammonia, 30:1:0.1) to afford 1 (40 mg) and 2 (11 mg). The retention times (tR) of 1–3 from analysis-type HPLC (50%→100% MeOH in H2O over 6.0 min followed by 100% MeOH to 10 min, 1.0 ml/min, 20℃) were 5.8, 4.7, and 6.6 min, respectively.
Rauvoyunine A (1): yellowish, amorphous powder; [α]D25 + 5.5 (c 0.10, MeOH); UV (MeOH) λmax: 216 (sh), 228, 282, 303, 316 (sh) nm; IR (KBr) νmax 3432, 2923, 1628, 1467, 1380, 1158, 1134 cm–1; 1H and 13C NMR data see Table 1; ESIMS (pos.): m/z 357 [M + H]+; HRESIMS (pos.): m/z 357.2185 (calc. for C21H29N2O3, 357.2178).
Rauvoyunine B (2): yellowish, amorphous powder; [α]D25 – 92.0 (c 0.19, MeOH); UV (MeOH) λmax: 231 (sh), 292 nm; IR (KBr) νmax 3440, 2951, 1738, 1622, 1454, 1385, 1236, 1146, 1114, 1048 cm–1; 1H and 13C NMR data see Table 1; ESIMS (pos.): m/z 427 [M + H]+; HRESIMS (pos.): m/z 427.1868 (calc. for C23H27N2O6, 427.1869).
Rauvoyunine C (3): yellowish, amorphous powder; [α]D25 – 116.8 (c 0.18, MeOH); UV (MeOH) λmax: 269, 293 (sh) nm; IR (KBr) νmax 3433, 2945, 1722, 1625, 1590, 1503, 1459, 1384, 1416, 1335, 1226, 1127 cm–1; 1H and 13C NMR data see Table 1; ESIMS (pos.): m/z 593 [M + H]+; HRESIMS (pos.): m/z 593.2496 (calc. for C32H37N2O9, 593.2499).
Cytotoxicity Assay. The cytotoxicity assay was performed according to the MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] method, 16 by use of the following five human cancer cell lines: human myeloid leukemia HL-60, hepatocellular carcinoma SMMC-7721, lung cancer A-549, breast cancer MCF-7, and colon cancer SW-480. The IC50 values were calculated by Reed and Muench's method.17
Notes
Electronic Supplementary Material
Supplementary material is available in the online version of this article at http://dx.doi.org/10.1007/s13659-011-0023-7 and is accessible for authorized users.
Acknowledgments
This work was financially supported by National Basic Research Program of China (973 Program) 2009CB522300, the "West Light" program of Chinese Academy of Sciences, and Natural Product Library Program of BioBioPha.
References
-
1.Editorial Committee of Flora Reipublicae Popularis Sinicae. Flora Reipublicae Popularis Sinicae; Academic Press: Beijing, 1977; Vol. 63, pp 46-58. PubMed Google Scholar
-
2.D. L. Bemis, J. L. Capodice, P. Gorroochurn, A. E. Katz, R. Buttyan, Int. J. Oncol. 29, 1065-1073 (2006) PubMed Google Scholar
-
3.C. W. Wright, J. D. Phillipson, S. O. Awe, G. C. Kirby, D. C. Warhurst, J. Quetin-Leclercq, L. Angenot, Phytother. Res. 10, 361-363 (1996) CrossRef PubMed Google Scholar
-
4.K. Hiwada, Ketsuatsu 13, 325-333 (2006) PubMed Google Scholar
-
5.Neuss, N. Indole and Biogenetically Related Alkaloids; Academic Press: New York, 1980; Chapter 17. PubMed Google Scholar
-
6.X. J. Hu, H. P. He, H. Zhou, Y. T. Di, X. W. Yang, X. J. Hao, L. Y. Kong, Helv. Chim. Acta 89, 1344-1350 (2006) CrossRef PubMed Google Scholar
-
7.B. H. Cheng, J. C. Chen, M. H. Qiu, Chin. Chem. Lett. 20, 1221-1223 (2009) CrossRef PubMed Google Scholar
-
8.H. B. Wang, X. K. Liu, Chem. J. Chin. Univ. 31, 2005-2009 (2010) PubMed Google Scholar
-
9.Y. Sheludko, I. Gerasimenko, H. Kolshorn, J. Stöckigt, J. Nat. Prod. 65, 1006-1010 (2002) CrossRef PubMed Google Scholar
-
10.K. Ghedira, M. Zeches-Hanrot, B. Richard, G. Massiot, L. Le Men-Olivier, T. Sevenet, S. H. Goh, Phytochemistry 27, 3955-3962 (1988) CrossRef PubMed Google Scholar
-
11.T. S. Kam, Y. M. Choo, J. Nat. Prod. 67, 547-552 (2004) CrossRef PubMed Google Scholar
-
12.T. S. Kam, Y. M. Choo, Tetrahedron 56, 6143-6150 (2000) CrossRef PubMed Google Scholar
-
13.N. Petitfrere-Auvray, J. Vercauteren, G. Massiot, G. Lukacs, T. Sevenet, L. Le Men-Olivier, B. Richard, M. J. Jacquier, Phytochemistry 20, 1987-1990 (1981) CrossRef PubMed Google Scholar
-
14.Y. Hirasawa, H. Arai, K. Zaima, R. Oktarina, A. Rahman, W. Ekasari, A. Widyawaruyanti, G. Indrayanto, N. C. Zaini, H. Morita, J. Nat. Prod. 72, 304-307 (2009) CrossRef PubMed Google Scholar
-
15.J. L. Pousset, J. Poisson, L. Olivier, J. Le Men, M. M. Janot, C. R. Acad. Sci. 261, 5538 (1965) PubMed Google Scholar
-
16.T. Mosmann, J. Immunol. Methods 65, 55-63 (1983) CrossRef PubMed Google Scholar
-
17.L. J. Reed, H. Muench, Am. J. Hyg. 27, 493-497 (1938) PubMed Google Scholar
Copyright information
© The Author(s) 2011
Open Access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.


